13:30 - 13:40 O2396 - Reduced Exercise Performance is Related to Number of Thoracic Surgeries in Children with Corrected TOF or Fontan Circulation
Graziella Eshuis, The Netherlands
13:40 - 13:50 O1262 - Mitochondrial Oxidant Stress and Iron Dysregulation in Doxorubicin-Induced Cardiomyopathy
John Charpie, US
13:50 - 14:00 O2961 - Lack of Rejection and Evidence of Autologous Cell Repopulation Following Heterotopic Implantation of Decellularized Pulmonary Homografts: Pathological Results in a Murine Model
Massimo Padalino, Italy
14:00 - 14:10 O1354 - Progress in the Generation of Multiple Lineage Human-IPSC-Derived 3D Engineeered Cardiac Tissues for Cardiac Repair
Bradley Keller, US
14:10 - 14:20 O2873 - Outcome of Paediatric Patients with CHD Transferred From Their Regional CICU to a Unit With Transplant and MCS Capability
Barbara Cardoso, UK
14:20 - 14:30 O2398 - Outcome Following Assessment of Paediatric Patients for Cardiac Transplant
Rebecca Johnson, UK
14:30 - 14:40 O2577 - Outcomes after Heart Transplant at Texas Children’s Hospital: Focus on Retransplantation
Rodrigo Zea-Vera, US
14:40 - 14:50 O2081 - Prospective Echocardiographic Evaluation of Ventricular Loading Conditions in Pediatric Patients with Pulsatile Flow LVAD
Arianna Di Molfetta, Italy
14:50 - 15:00 O2035 - Pilot Study of Warfarin Genotype Polymorphisms in Children with VAD
Francesca Iodice, Italy
15:00 - 15:10 O3031 - A Novel, Miniature Implantable Continuous Flow Pediatric VAD
Peter Wearden, US
15:10 - 15:20 O3027 - The Pumpkin Trial: Study Design and Rationale
Christopher Almond, US
15:20 - 15:30 Discussion